Skolnick, Phil

Functional antagonists at the NMDA receptor complex exhibit antidepressant actions

Trullas, R., & Skolnick, P. (1990) · European Journal of Pharmacology

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 785

Glutamate and Depression: Clinical and Preclinical Studies

PAUL, I. A., & SKOLNICK, P. (2003) · Annals of the New York Academy of Sciences

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 408

The Opioid Epidemic: Crisis and Solutions

Skolnick, P. (2018) · Annual Review of Pharmacology and Toxicology

Opioid Use Disorder TreatmentPain Management and Opioid Use

Cited by 307

Antidepressant-like actions of an AMPA receptor potentiator (LY392098)

Li, X., Tizzano, J. P., Griffey, K., Clay, M., Lindstrom, T., & Skolnick, P. (2001) · Neuropharmacology

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 225

Mitigating the Effects of Nonadherence in Clinical Trials

Shiovitz, T. M., Bain, E. E., McCann, D. J., Skolnick, P., Laughren, T., Hanina, A., & Burch, D. (2016) · The Journal of Clinical Pharmacology

Statistical Methods in Clinical TrialsMedication Adherence and Compliance

Cited by 114

Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets

Bespalov, A., Steckler, T., Altevogt, B., Koustova, E., Skolnick, P., Deaver, D., Millan, M. J., Bastlund, J. F., Doller, D., Witkin, J., et al. (2016) · Nature Reviews Drug Discovery

Animal testing and alternativesComputational Drug Discovery Methods

Cited by 84

Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial

Tran, P., Skolnick, P., Czobor, P., Huang, N. Y., Bradshaw, M., McKinney, A., & Fava, M. (2012) · Journal of Psychiatric Research

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 81

Environmentally-induced modification of the benzodiazepine/GABA receptor coupled chloride ionophore

Trullas, R., Havoundjian, H., Zamir, N., Paul, S., & Skolnick, P. (1987) · Psychopharmacology

Neuroscience and Neuropharmacology ResearchReceptor Mechanisms and Signaling

Cited by 78

Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell cultures

Boje, K. M., Wong, G., & Skolnick, P. (1993) · Brain Research

Neuroscience and Neuropharmacology ResearchAmino Acid Enzymes and Metabolism

Cited by 69

Characterization of the Binding of [3H]Ro 5‐4864, a Convulsant Benzodiazepine, to Guinea Pig Brain

Weissman, B. A., Bolger, G. T., Isaac, L., Paul, S. M., & Skolnick, P. (1984) · Journal of Neurochemistry

Neuroscience and Neuropharmacology ResearchEpilepsy research and treatment

Cited by 64

Be positive about negatives–recommendations for the publication of negative (or null) results

Bespalov, A., Steckler, T., & Skolnick, P. (2019) · European Neuropsychopharmacology

Academic Writing and PublishingAcademic Publishing and Open Access

Cited by 59

Chronic exposure to benzodiazepine receptor ligands uncouples the gamma-aminobutyric acid type A receptor in WSS-1 cells.

Wong, G., Lyon, T., & Skolnick, P. (1994) · Molecular Pharmacology

Neuroscience and Neuropharmacology ResearchReceptor Mechanisms and Signaling

Cited by 36

Pharmacological Properties of DOV 315,090, an ocinaplon metabolite

Berezhnoy, D., Gravielle, M. C., Downing, S., Kostakis, E., Basile, A. S., Skolnick, P., Gibbs, T. T., & Farb, D. H. (2008) · BMC Pharmacology

Neuroscience and Neuropharmacology ResearchEpilepsy research and treatment

Cited by 18